Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Stopped early
Conditions studied: Myeloproliferative Disorders, Myeloproliferative Disorders (MPD)
In brief
The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.
Key facts
- Study ID
- NCT01144780
- Run by
- Stanford University
- People needed
- 10
- Starts
- 2009-09-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2020-04-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.